Oral solids remain the preferred route of drug delivery due to their cost-effectiveness, ease of manufacturing, and patient-friendly dose form options.
Both the Council for Responsible Nutrition and the BBB’s National Advertising Division are optimistic about the industry’s ongoing self-regulatory efforts.